64907-55-7 Usage
Class of 1,2,4-triazole compounds
1H-1,2,4-Triazole,5-bromo-1-ethyl-(9CI) belongs to a specific class of chemicals called 1,2,4-triazole compounds, which have a specific structure and properties.
Presence of bromine atom
The presence of a bromine atom in the compound can affect its chemical properties, such as reactivity and polarity.
Presence of an ethyl group
The presence of an ethyl group in the compound can also affect its chemical properties, such as solubility and reactivity.
Used in various applications
1H-1,2,4-Triazole,5-bromo-1-ethyl-(9CI) is used in a variety of fields, including pharmaceuticals, agrochemicals, and materials science.
Potential biological activities
The compound has been studied for its potential biological activities, including as an antifungal and antibacterial agent.
Building block in organic synthesis
The compound has been explored as a building block in organic synthesis, which can be used to create more complex molecules.
Ligand in coordination chemistry
The compound has been studied as a ligand in coordination chemistry, which can be used to create new compounds with unique properties.
Check Digit Verification of cas no
The CAS Registry Mumber 64907-55-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,9,0 and 7 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 64907-55:
(7*6)+(6*4)+(5*9)+(4*0)+(3*7)+(2*5)+(1*5)=147
147 % 10 = 7
So 64907-55-7 is a valid CAS Registry Number.
64907-55-7Relevant academic research and scientific papers
NOVEL CYP17 INHIBITORS/ANTIANDROGENS
-
Page/Page column 73; 74, (2015/01/07)
Compounds of formula (I), wherein R1 to R8 A, B, Z1 and Z2 are as defined in the claims and pharmaceutically acceptable salts and esters thereof are disclosed. The compounds of formula (I) possess utility as androgen receptor antagonists (inhibitors) and/or cytochrome P450 monooxygenase 17a-hydroxylase/17,20-lyase (CYP17) inhibitors. The compounds are useful as medicaments in the treatment of cancer, particularly prostate cancer, and other androgen dependent conditions and diseases where androgen antagonism is desired.
